申请人:Thomas Abraham
公开号:US20080076818A1
公开(公告)日:2008-03-27
The present invention relates to novel processes for preparing DPP-IV inhibitors having the structure of formula I,
and pharmaceutically acceptable salt thereof, which are useful for treatment of Type 2 diabetes.
本发明涉及一种新型制备DPP-IV抑制剂的方法,其具有公式I的结构和药学上可接受的盐,对于治疗2型糖尿病具有用处。